PAULA SUTER: Open Payments
NPI 1407605892 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,334 in 51 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $272 · 2025 $1,334
Food & beverage: $1,334
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $503 |
| Novo Nordisk Inc | 12 | $262 |
| ABBVIE INC. | 4 | $155 |
| Lilly USA, LLC | 4 | $71 |
| SANOFI-AVENTIS U.S. LLC | 3 | $57 |
| Medtronic, Inc. | 3 | $57 |
| Dexcom, Inc. | 3 | $54 |
| PFIZER INC. | 3 | $49 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
Products named: AIRSUPRA, FARXIGA, BREZTRI, Wegovy, UBRELVY, TZIELD, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across TX — which companies pay providers there.
